Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $61.83M.
ENTERPRISE VALUE (EV)
$61.83M
Cingulate Inc.
Market Cap
$65.33M
Enterprise Value (EV)
$61.83M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cingulate Inc. (CING) | $65.33M | $61.83M |
| RenovoRx, Inc. (RNXT)vs › | $65.33M | $56.11M |
| InterCure Ltd. (INCR)vs › | $65.15M | $108.00M |
| Gossamer Bio, Inc. (GOSS)vs › | $65.02M | $62.97M |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.90M | $191.53M |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | $67.64M |
| Alps Group Inc (ALPS)vs › | $63.23M | N/A |
| Fortress Biotech, Inc. (FBIO)vs › | $68.44M | N/A |
| iBio, Inc. (IBIO)vs › | $68.81M | $14.61M |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.77M | $20.00M |
Market Cap
$65.33M
Total Debt
$7.45M
Cash
$10.95M
Enterprise Value
$61.83M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
